Skip to main content
Radiology: Cardiothoracic Imaging logoLink to Radiology: Cardiothoracic Imaging
letter
. 2020 May 27;2(3):e200256. doi: 10.1148/ryct.2020200256

Accuracy of Low-Dose Chest CT Scan in Detection of COVID-19

Hooman Bahrami-Motlagh 1,, Morteza Sanei Taheri 1, Sahar Abbasi 1, Maryam Haghighimorad 1, Babak Salevatipour 1, Ilad Alavi Darazam 1
PMCID: PMC7325500  PMID: 33778592

Editor:

We read the informative article published by Dangis et al in the journal about the accuracy of low-dose chest CT in the diagnosis of COVID-19 disease (1). Considering that in many settings chest CT scan is used widely for detection of COVID-19 pneumonia, using a low-dose protocol especially in patients younger than 40 years is important. This interesting study reported accuracy of 90.2% in all patients and 94% in the subset of patients with chest CT performed 48 hours after the symptom’s onset. The sensitivity and specificity values were respectively 86.7% and 93.6%, while in a recent meta-analysis including 63 studies, Kim et al (2) reported combined sensitivity and specificity of chest CT for the diagnosis of COVID -19, considering PCR test as the reference standard, as 94% and 37%, respectively. Pooled prevalence of COVID-19 mainly from reports in China is about 39%, which is near to what Dangis et al (1) report with described pretest probability of 43%. Additionally, we have conducted a study in Tehran, Iran, utilizing low-dose chest CT on 163 patients and observed a sensitivity value of 96.6% (95% CI: 90%, 99%), and specificity value of 36.5% (95% CI: 26%, 49%) (unpublished results), more compatible with the numbers in the mentioned meta-analysis. Although Dangis et al (1) stated that a potential reason for their high specificity was the repeated RT-PCR test after 24 hours in cases with initial negative RT-PCR result, the specificity of standard-dose CT scan in four previous studies with repeated RT-PCR have ranged between 25% and 56% (3-6). It seems that other explanations for the observed high specificity of low-dose chest CT should be explored. Additionally, the specificity of low-dose CT scan for subset of patients with initial negative RT-PCR results are not reported separately in their study.

In conclusion, this remarkable study by Dangis et al (1) demonstrates excellent accuracy of low-dose chest CT in the diagnosis of COVID-19 pneumonia, with exceptional high specificity compared to previous standard-dose studies, which remains to be further validated.

References

  • 1.Dangis A, Gieraerts C, Bruecker YD, Janssen L, Valgaeren H, Obbels D, Gillis M, Ranst MV, Frans J, Demeyere A, Symons R. Accuracy and reproducibility of low-dose submillisievert chest CT for the diagnosis of COVID-19. Radiol: Cardiothoracic Imaging. 2020 Apr 21;2(2):e200196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kim H, Hong H, Yoon SH. Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis. Radiology. 2020 Apr 17:201343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020 Feb 26:200642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China. Journal of Medical Virology. 2020 Mar 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cheng Z, Lu Y, Cao Q, Qin L, Pan Z, Yan F, Yang W. Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. American Journal of Roentgenology. 2020 Mar 14:1-6. [DOI] [PubMed] [Google Scholar]
  • 6.Caruso D, Zerunian M, Polici M, Pucciarelli F, Polidori T, Rucci C, Guido G, Bracci B, de Dominicis C, Laghi A. Chest CT features of COVID-19 in Rome, Italy. Radiology. 2020 Apr 3:201237. [DOI] [PMC free article] [PubMed] [Google Scholar]
Radiol Cardiothorac Imaging. 2020 May 27;2(3):e200256. doi: 10.1148/ryct.2020200290

Response

Anthony Dangis 1, Christopher Gieraerts 1, Yves De Bruecker 1, Lode Janssen 1, Hanne Valgaeren 1, Dagmar Obbels 1, Marc Gillis 1, Marc Van Ranst 1, Johan Frans 1, Annick Demeyere 1, Rolf Symons 1,

We thank the authors for their interest in our article (1). The plethora of research articles on coronavirus disease 2019 (COVID-19) may tempt us to directly compare studies or translate results to our own daily routine. It is important, however, to realize that measurements of diagnostic accuracy such as sensitivity and specificity are only valid for the study population from which they are obtained and for the reference test against which they are compared.

First, the use of low-sensitivity real-time polymerase chain reaction (RT-PCR) reference tests in early studies from China leads to an underestimation of CT specificity and is directly mentioned by Ai et al in their study limitations (2). As the vast majority of studies in the meta-analysis by Kim et al originate from China, their likely use of low-sensitivity RT-PCR assays explains the observed low specificity (3). Caruso et al from Italy do not directly mention the sensitivity of their RT-PCR assay, but as this study included 96 RT-PCR negative subjects of which 42 had positive findings on chest CT, it is very likely that part of these “false positives” on CT were in fact true positives (4). In a reader study eliminating effects of an imperfect reference test, Bai et al reported specificity of 93%–100%, similar to our results (5). Our RT-PCR was externally validated against the National Reference Laboratory of University Hospitals, Leuven, Belgium as well as in two international independent External Quality Control (EQC) Programs (QCMD, Scotland, UK, and Instand, Düsseldorf, Germany, www.instand-ev.de).

Second, there is an inherent trade-off between test sensitivity and specificity. In a situation with limited availability of an imperfect reference test, sensitivity is typically preferred over specificity, and a low threshold for diagnosis is used. As previous studies reported a very high sensitivity (97% vs 86% in our study), this negatively affected specificity (2,4).

Third, our study should not be read as superior performance of low-dose versus standard-dose CT. However, excellent reproducibility and accuracy suggests low dose is sufficient for diagnosis, and radiation exposure should be reduced. We used CareDose4D (Siemens Healthineers) to adapt radiation parameters, including CarekV which selects the optimal tube voltage. New techniques may even further reduce radiation exposure (6).

Fourth, the prevalence of pneumonia from non-COVID-19 viruses (the most challenging differential diagnosis of COVID-19 on CT) in our cohort was very low, further increasing CT specificity.

In conclusion, differences in study populations and reference tests change the estimated performance of a screening test. Careful consideration of these differences is necessary in order to place research results in a proper clinical context.

References

  • 1.Dangis A, Gieraerts C, Bruecker Y De, et al. Accuracy and reproducibility of low-dose submillisievert chest CT for the diagnosis of COVID-19. Radiol Cardiothorac Imaging. 2020;2(2):e200196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;200642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kim H, Hong H, Yoon SH. Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis. Radiology. 2020;201343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Caruso D, Zerunian M, Polici M, et al. Chest CT features of COVID-19 in Rome, Italy. Radiology. 2020;201237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;200823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Symons R, Pourmorteza A, Sandfort V, et al. Feasibility of Dose-reduced Chest CT with Photon-counting Detectors: Initial Results in Humans. Radiology. 2017;162587. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Radiology: Cardiothoracic Imaging are provided here courtesy of Radiological Society of North America

RESOURCES